Belgium vs Northern Africa: Proportion of the target population who received a 3rd dose of
Belgium
94.0%
in 2024
Northern Africa
37.0%
in 2024
Belgium rank
36th
Northern Africa rank
35th
Proportion of the target population who received a 3rd dose of over time
- Belgium
- Northern Africa
How they compare
Belgium currently reports 94.0% against 37.0% in Northern Africa, a difference of 57.0%.
That makes Belgium's figure about 2.5 times Northern Africa's.
Across all 13 years both countries report, Belgium has been ahead every year.
Belgium ranks 36th and Northern Africa ranks 35th of 157 countries.
Belgium has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belgium | Northern Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.6% | 35.8% | 57.9% | Belgium |
| 2020s | 94.0% | 45.6% | 48.4% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Belgium or Northern Africa?
- Belgium, at 94.0% against 37.0% in Northern Africa as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Belgium and Northern Africa?
- 57.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Northern Africa?
- 13 years are reported by both, from 2012 to 2024.
- How do Belgium and Northern Africa rank globally for proportion of the target population who received a 3rd dose of?
- Belgium ranks 36th and Northern Africa ranks 35th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.